Without fanfare, the U.S. Centers for Disease Control and Prevention, August 11, 2022, reversed all its COVID-19 guidelines. In fact, many have noted it appears the CDC wanted to bring as little attention to it as possible.1 This is understandable, considering the new guidelines more or less admit the original rules were in error, without… Read More: CDC Backtracks on COVID Guidance as Damning Studies Mount »
This article was previously published September 5, 2018, and has been updated with new information. Sucralose (sold under the brand name Splenda) was approved by the U.S. Food and Drug Administration (FDA) in 19981 as a tabletop sweetener and for use in products such as baked goods, nonalcoholic beverages, chewing gum, frozen dairy desserts, fruit… Read More: New Splenda Studies Confirm Its Dangers »
Food-derived peptides with biological activity: from research to food applications. Abstract The goal of this paper is to review the evidence related to the effect of plant-based dietary patterns on obesity and weight loss, including both observational and intervention trials. The work must be attributed back to the original author and commercial use is not… Read More: Studies to support fat based diet »